Glycogen storage diseases arise from enzyme deficiencies in the glycogen synthesis/degradation pathway of biochemistry: glycogen is built from glucose via alpha-1,4 linear bonds and alpha-1,6 branch bonds (formed by the branching enzyme), and broken down via phosphorylases (cleaving alpha-1,4 bonds), the debranching enzyme (cleaving alpha-1,6 bonds), and glucose-6-phosphatase (releasing free glucose from glucose-6-phosphate). Deficiency of any specific enzyme in this pathway produces a distinct storage disease, classifiable by which tissue's enzyme isoform is affected (muscle, liver, or both), since phosphorylase and other enzymes exist in tissue-specific isoforms (muscle, hepatic, lysosomal/lysosomal maltase). This framework situates glycogen storage disease within metabolic biochemistry as a model of enzyme-deficiency disorders producing predictable, mechanism-derived clinical syndromes (hepatomegaly/hypoglycemia/hyperlipidemia from failed glucose mobilization, or muscle-specific energy-use symptoms from failed glycogenolysis in muscle).
Glycogen storage diseases arise from enzyme deficiencies in the glycogen synthesis/degradation pathway of biochemistry: glycogen is built from glucose via alpha-1,4 linear bonds and alpha-1,6 branch …